[go: up one dir, main page]

HU911132D0 - Process for producing carbapenem compounds - Google Patents

Process for producing carbapenem compounds

Info

Publication number
HU911132D0
HU911132D0 HU911132A HU113291A HU911132D0 HU 911132 D0 HU911132 D0 HU 911132D0 HU 911132 A HU911132 A HU 911132A HU 113291 A HU113291 A HU 113291A HU 911132 D0 HU911132 D0 HU 911132D0
Authority
HU
Hungary
Prior art keywords
carbapenem compounds
producing carbapenem
producing
compounds
carbapenem
Prior art date
Application number
HU911132A
Other languages
English (en)
Other versions
HUT57769A (en
Inventor
Scott Louis Dax
Dennis Dalton Keith
Pamela Loreen Rossman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HU911132D0 publication Critical patent/HU911132D0/hu
Publication of HUT57769A publication Critical patent/HUT57769A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU911132A 1990-04-09 1991-04-08 Process for producing coarbapenem compounds and pharmaceutical compositions comprising same HUT57769A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (2)

Publication Number Publication Date
HU911132D0 true HU911132D0 (en) 1991-10-28
HUT57769A HUT57769A (en) 1991-12-30

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
HU911132A HUT57769A (en) 1990-04-09 1991-04-08 Process for producing coarbapenem compounds and pharmaceutical compositions comprising same

Country Status (17)

Country Link
EP (1) EP0451764A1 (hu)
JP (1) JPH04234884A (hu)
AU (1) AU7420591A (hu)
BR (1) BR9101418A (hu)
CA (1) CA2039987A1 (hu)
CS (1) CS94391A2 (hu)
FI (1) FI911666A7 (hu)
HU (1) HUT57769A (hu)
IE (1) IE911161A1 (hu)
IL (1) IL97797A0 (hu)
MC (1) MC2262A1 (hu)
MX (1) MX25231A (hu)
NO (1) NO911357L (hu)
PT (1) PT97287A (hu)
TW (1) TW216420B (hu)
YU (1) YU62991A (hu)
ZA (1) ZA912279B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
SG47533A1 (en) * 1990-04-18 1998-04-17 Procter & Gamble Pharma Antimicrobial quinolonyl lactams
ATE150463T1 (de) * 1991-10-01 1997-04-15 Procter & Gamble Pharma Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
CA2196539C (en) * 1994-08-02 2001-05-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
NZ290721A (en) * 1994-08-02 1999-03-29 Procter & Gamble Process for making quinolone-containing antimicrobial compounds
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0971889B1 (en) * 1997-01-21 2003-08-13 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
DE68929227T2 (de) * 1988-10-24 2001-05-31 Procter & Gamble Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactamester

Also Published As

Publication number Publication date
MC2262A1 (fr) 1993-04-26
CS94391A2 (en) 1991-11-12
ZA912279B (en) 1992-02-26
IE911161A1 (en) 1991-10-09
YU62991A (sh) 1994-04-05
EP0451764A1 (en) 1991-10-16
BR9101418A (pt) 1991-11-26
FI911666A0 (fi) 1991-04-08
FI911666A7 (fi) 1991-10-10
MX25231A (es) 1993-10-01
NO911357D0 (no) 1991-04-08
NO911357L (no) 1991-10-10
PT97287A (pt) 1992-01-31
AU7420591A (en) 1991-10-10
TW216420B (hu) 1993-11-21
HUT57769A (en) 1991-12-30
CA2039987A1 (en) 1991-10-10
JPH04234884A (ja) 1992-08-24
IL97797A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
HUT61600A (en) Process for producing l-triptophane
HU912903D0 (en) Method for producing azocyclic compounds
HUT70895A (en) Process for producing alfa-alumina
HUT63199A (en) Process for producing l-treonin
HUT62898A (en) Process for producing pyrazolo- and triazolotriazine compounds
HU911132D0 (en) Process for producing carbapenem compounds
HUT56825A (en) Process for producing substituted 2-chloropyridines
HUT59695A (en) Process for producing hydroxy-ethyl-amine- and norstai
HUT58785A (en) Process for producing hypoallergene moth-oils
IL99513A0 (en) Process for the preparation of carbapenem compounds
HUT58699A (en) Process for producing 2-chloro-5-methyl-pyridine
EP0430037A3 (en) Process for producing 2-carbon-substituted carbapenem derivatives
HUT71335A (en) Process for producing substituted imidazole compounds
HU9202920D0 (en) Process for producing 1-hydroxyalkyl-5-nitroimidazoles
HU910745D0 (en) Process for producing 1-treonine
HUT60239A (en) Process for producing glian
HU910578D0 (en) Process for producing 4-hydroxiphenethyl-alcohol
SG49204A1 (en) Process for producing alkadienols
HU910734D0 (en) Process for producing cephalosporine derivatives
EP0543633A3 (en) Process for producing 4-amino-3-fluorobenzotrifluoride
GB2267705B (en) Process for producing 2-alkyl-4-halo-5-formylimidazoles
HUT64029A (en) Process for producing 2-aminometnhylpyridine
RO105814B1 (ro) Procedeu de obtinere a copolimerului polidimetilhidrogenmetilsiloxan
HU911601D0 (en) Process for producing phenyl-piperazines
EP0485783A3 (en) Process for producing epoxy compounds

Legal Events

Date Code Title Description
DFC9 Refusal of application